Swainsonine reduces 5-fluorouracil tolerance in the multistage resistance of colorectal cancer cell lines

Molecular Cancer

Volumn 6, Issue , 2007, Pages

  Hamaguchi, Jun ^a   Nakagawa, Hiroaki ^b   Takahashi, Masato ^a   Kudo, Takeaki ^a   Kamiyama, Naoya ^c   Sun, Bailong ^a   Oshima, Takahiro ^a   Sato, Yuji ^a   Deguchi, Kisaburo ^b   Todo, Satoru ^a   Nishimura, Shin Ichiro ^b  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

^c ASAHIKAWA MEDICAL COLLEGE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DIHYDROPYRIMIDINE DEHYDROGENASE; FLUOROURACIL; GLYCOPEPTIDASE; OROTIC ACID; SWAINSONINE; THYMIDYLATE SYNTHASE; MESSENGER RNA; POLYSACCHARIDE;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BIOSYNTHESIS; CANCER CHEMOTHERAPY; CYTOTOXICITY; DRUG DEGRADATION; DRUG INHIBITION; DRUG POTENTIATION; DRUG RESISTANCE; DRUG SENSITIVITY; IC 50; MOUSE; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN SYNTHESIS INHIBITION; QUALITY OF LIFE; ANIMAL; CELL SURVIVAL; COLORECTAL TUMOR; DRUG EFFECT; DRUG TOLERANCE; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; CELL SURVIVAL; COLORECTAL NEOPLASMS; DRUG RESISTANCE, NEOPLASM; DRUG TOLERANCE; FLUOROURACIL; GENE EXPRESSION REGULATION, NEOPLASTIC; MICE; POLYSACCHARIDES; RNA, MESSENGER; SWAINSONINE;

EID: 36048960876     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-6-58     Document Type: Article

References (49)

1. Allen WL Coyle VM Johnston PG Predicting the outcome of chemotherapy for colorectal cancer Corr Opin Pharmacol 2006, 6:332-336 10.1016/ j.coph.2006.02.005
2. Pinedo HM Peters GF Fluorouracil: Biochemistry and pharmacology J Clin Oncol 1988, 6:1653-1664 3049954
3. Kanamaru R Wakui A Mechanism of action of anti-cancer drugs from the viewpoint of RNA metabolism Gan To Kagaku Ryoho 1988, 15:1011-1018 3291764
4. Longley DB Harkin DP Johnston PG 5-Fluorouracil: Mechanisms of action and clinical strategies Nat Rev Cancer 2003, 3:330-338 10.1038/nrc1074 12724731
5. Mader RM Müller M Steger GG Resistance to 5-fluorouracil Gen Pharmac 1998, 31:661-666
6. Maring JG Groen HJ Wachters FM Uges DR de Vries EG Genetic factors influencing pyrimidine-antagonist chemotherapy Pharmacogenemics J 2005, 5:226-243 10.1038/sj.tpj.6500320
7. Longley DB Allen WL Johnston PG Drug resistance, predictive markers and pharmacogenomics in colorectal cancer Biochem Biophys Acta 2006, 1766:184-196 16973289
8. Ooyama A Okayama Y Takechi T Sugimoto Y Oka T Fukushima M Genome-wide screening of loci associated with drug resistance to 5-fluorouracil-based drugs Cancer Sci 2007, 98:577-583 10.1111/ j.1349-7006.2007.00424.x 17425594
9. Varki A Biological roles of oligosaccharides: All of the theories are correct Glycobiology 1993, 3:97-130 10.1093/glycob/3.2.97 8490246
10. Dwek RA Glycobiology: Toward understanding the function of sugars Chem Rev 1996, 96:683-720 10.1021/cr940283b 11848770
11. Hakomori S-i Tumor malignancy defined by aberrant glycosylation and Sphingo (glyco) lipid metabolism Cancer Res 1996, 56:5309-5318 8968075
12. Nakahara S Miyoshi E Noda K Ihara S Gu J Honke K Inohara H Kubo T Taniguchi N Involvement of oligosaccharide changes in α 5β 1 integrin in a cisplatin-resistant human squamous cell carcinoma cell line Mol Cancer Ther 2003, 2:1207-1214 14617794
13. Kudo T Nakagawa H Takahashi M Hamaguchi J Kamiyama N Yokoo H Nakanishi K Nakagawa T Kamiyama T Deguchi K Nishimura S-I Todo S N-glycan alternations are associated with drug resistance in human hepatocellular carcinoma Mol Cancer 2007, 6:32 1878497 17488527 10.1186/1476-4598-6-32
14. Helenius A Aebi M Intracellular functions of N-linked glycans Science 2001, 291:2364-2369 10.1126/science.291.5512.2364 11269317
15. Kornfeld R Kornfeld S Assembly of asparagine-linked oligosaccharides Annu Rev Biochem 1985, 54:631-664 10.1146/annurev.bi.54.070185.003215 3896128
16. Fuhrmann U Bause E Ploegh H Inhibitors of oligosaccharide processing Biochim Biophys Acta 1985, 825:95-110 3159432
17. Elbein AD Glycosidase inhibitors: Inhibitors of N-linked oligosaccharide processing FASEB J 1991, 5:3055-3063 1743438
18. Dorling PR Huxtable CR Colegate SM Inhibition of lysosomal α-mannosidase by swainsonine, an indolizidine alkaloid isolated from Swainsona canescens Biochem J 1980, 191:649-651 1162258 6786280
19. Tulsiani DRP Harris TM Touster O Swainsonine inhibits the biosynthesis of complex glycoproteins by inhibition of Golgi mannosidase II J Biol Chem 1982, 257:7936-7939 6806288
20. Elbein AD Dorling PR Vosbeck K Horisberger M Swainsonine prevents the processing of the oligosaccharide chains of influenza virus hemagglutinin J Biol Chem 1982, 257:1573-1576 6799507
21. Yoon S-J Nakayama K-i Hikita T Handa K Hakomori S-i Epidermal growth factor receptor tyrosine kinase is modulated by GM3 interaction with N-linked GlcNAc termini of the receptor Proc Natl Acad Sci USA 2006, 103:18987-18991 1748164 17142315 10.1073/pnas.0609281103
22. Lagana A Goetz JG Cheung P Raz A Dennis JW Nabi IR Galectin binding to Mgat5-modified N-glycans regulates fibronectin matrix remodeling in tumor cells Mol Cell Biol 2006, 26:3181-3193 1446937 16581792 10.1128/ MCB.26.8.3181-3193.2006
23. Goss PE Baker MA Carver JP Dennis JW Inhibitors of carbohydrate processing: A new class of anticancer agents Clin Cancer Res 1995, 1:935-944 9816064
24. Dennis JW Effects of swainsonine and polyinosinic: Polycytidylic acid on murine tumor cell growth and metastasis Cancer Res 1986, 46:5131-5136 3093060
25. Dennis JW Koch K Yousefi S VanderElst I Growth inhibition of human melanoma tumor xenografts in athymic nude mice by swainsonine Cancer Res 1990, 50:1867-1872 2106389
26. Oredipe OA White SL Grzegorzewski K Gause BL Cha JK Miles VA Olden K Protective effects of swainsonine on murine survival and bone marrow proliferation during cytotoxic chemotherapy J Natl Cancer Inst 1991, 83:1149-1156 10.1093/jnci/83.16.1149 1909378
27. Klein J-LD Roberts JD George MD Kurtzberg J Breton P Chermann J-C Olden K Swainsonine protects both murine and human haematopoietic systems from chemotherapeutic toxicity Brit J Cancer 1999, 80:87-95 10.1038/ sj.bjc.6690326 10389983
28. Humphries MJ Matsumoto K White SL Molyneux RJ Olden K Augmentation of murine natural killer cell activity by swainsonine, a new antimetastatic immunomodulator Cancer Res 1988, 48:1410-1415 3125963
29. Bowlin TL McKown BJ Kang MS Sunkara PS Potentiation of human lymphokine-activated killer cell activity by swainsonine, an inhibitor of glycoprotein processing Cancer Res 1989, 49:4109-4133 2501020
30. Goss PE Baptiste J Fernandes B Baker M Dennis JW A phase I study of swainsonine in patients with advanced malignancies Cancer Res 1994, 54:1450-1457 8137247
31. Goss PE Reid CL Bailey D Dennis JW Phase IB clinical trial of oligosaccharide processing inhibitor swainsonine in patients with advanced malignancies Clin Cancer Res 1997, 3: 077-1086 9815786
32. Noda I Fujieda S Seki M Tanaka N Sunaga H Ohtsubo T Tsuzuki H Fan G-K Saito H Inhibition of N-linked glycosylation by tunicamycin enhances sensitivity to cisplatin in human head-and-neck carcinoma cells Int J Cancer 1999, 80:279-284 10.1002/ (SICI)1097-0215(19990118)80:2<279::AID-IJC18>3.0.CO;2-N 9935211
33. Hiss DC Gabriels GA Folb PI Combination of tunicamycin with anticancer drugs synergistically enhances their toxicity in multidrug-resistant human ovarian cystadenocarcinoma cells Cancer Cell Int 2007, 7:5 1865531 17439664 10.1186/1475-2867-7-5
34. Takahashi N Tomiya N Analysis of N-linked oligosaccharides: Application of glycoamidase A Handbook of endoglycosidases and glycoamidases Boca Raton, CRC Press Takahashi N, Muramatsu T 1992:199-332
35. van Triest B Pinedo HM van Hensbergen Y Smid K Telleman F Schoenmakers PS van der Wilt CL van Laar JAM Noordhuis P Jansen G Peters GJ Thymidylate synthase level as the main predictive parameter for sensitivity to 5-fluorouracil, but not for folate-based thymidylate synthase inhibitors, in 13 nonselected colon cancer cell lines Clin Cancer Res 1999, 5:643-654 10100718
36. Fujii R Seshimo A Kameoka S Relationships between the expression of thymidylate synthase, dihydropyrimidine dehydrogenase, and orotate phosphoribosyltransferase and cell proliferative activity and 5-fluorouracil sensitivity in colorectal carcinoma Int J Clin Oncol 2003, 8:72-78 10.1007/s101470300013 12720098
37. Oguri T Achiwa H Bessho Y Muramatsu H Maeda H Niimi T Sato S Ueda R The role of thymidylate syntase and dihydropyrimidine dehydrogenase in resistance to 5-fluorouracil in human lung cancer cells Lung Cancer 2005, 49:345-351 10.1016/j.lungcan.2005.05.003 15993511
38. Akama TO Nakagawa H Wong NK Sutton-Smith M Dell A Morris HR Nakayama J Nishimura S-I Pai A Moremen KW Marth JD Fukuda MN Essential and mutually compensatory roles of α-mannosidase II and α-mannosidase IIx in N-glycan processing in vivo in mice Proc Natl Acad Sci USA 2006, 103:8983-8988 1474017 16754854 10.1073/pnas.0603248103
39. Hato M Nakagawa H Kurogochi M Akama TO Marth JD Fukuda MN Nishimura S-I Unusual N-glycan Structures in α-mannosidase II/IIx double null embryos identified by a systematic glycomics approach based on two-dimensional LC mapping and matrix-dependent selective fragmentation method in MALDI-TOF/TOF mass spectrometry Mol Cell Proteomics 2006, 5:2146-2157 10.1074/mcp.M600213-MCP200 16899540
40. Chui D Oh-Eda M Liao Y-F Panneerselvam K Lal A Marek KW Freeze HH Moremen KW Fukuda MN Marth JD Alpha-mannosidase-II deficiency results in dyserythropoiesis and unveils an alternate pathway in oligosaccharide biosynthesis Cell 1997, 90:157-167 10.1016/S0092-8674(00)80322-0 9230311
41. Sato W Fukazawa N Nakanishi O Baba M Suzuki T Yano O Naito M Tsuruo T Reversal of multidrug resistance by a novel quinoline derivative, MS-209 Cancer Chemother Pharmacol 1995, 35:271-277 10.1007/BF00689444 7828268
42. Dieras V Bonneterre J Laurence V Degardin M Pierga J-Y Bonneterre M-E Marreaud S Lacombe D Fumoleau P Phase I combining a P-glycoprotein inhibitor, MS209, in combination with docetaxel in patients with advanced malignancies Clin Cancer Res 2005, 11:6256-6260 10.1158/ 1078-0432.CCR-04-2316 16144929
43. Corbett TH Griswold DP Jr Roberts BJ Peckham JC Schabel FM Jr Tumor induction relationships in development of transplantable cancers of the colon in mice for chemotherapy assays, with a note on carcinogen structure Cancer Res 1975, 35:2434-2439 1149045
44. Kawada M Inoue H Usami I Takamoto K Masuda T Yamazaki Y Ikeda D Establishment of a highly tumorigenic LNCaP cell line having inflammatory cytokine resistance Cancer Lett 2006, 242:46-52 10.1016/ j.canlet.2005.10.040 16377078
45. Mosmann T Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays J Immunol Methods 1983, 65:55-63 10.1016/0022-1759(83)90303-4 6606682
46. Kobayashi H Higashiyama M Minamigawa K Tanisaka K Takano T Yokouchi H Kodama K Hata T Examination of in vitro chemosensitivity test using collagen gel droplet culture method with colorimetric endpoint quantification Jpn J Cancer Res 2001, 92:203-210 11223550
47. Hase S Ikenaka T Matsushima Y Structure analyses of oligosaccharides by tagging of the reducing end sugars with a fluorescent compound Biochem Biophys Res Commun 1978, 85:257-263 10.1016/S0006-291X(78)80037-0 743278
48. Yamamoto S Hase S Fukuda S Sano O Ikenaka T Structures of the sugar chains interferon-γ produced by human myelomocyte cell line HBL-38 J Biochem 1989, 105:547-555 2503497
49. http://www.glycoanalysis.info/